Published: 8. March, 2022
Cessatech reports successful outcome of bioavailability trial 0204 Topline results of clinical trial 0204…
Cessatech reports successful outcome of bioavailability trial 0204
Topline results of clinical trial 0204 investigating the absolute bioavailability of CT001 showed clinical relevant exposures following nasal administration. Primary aim of the trial was to investigate drug-exposure following nasal administration of CT001 relative to the IV injection of the approved drug counterparts.
220308 – 0204 successful topline results
